Literature DB >> 10602056

A role for lymphatic endothelium in the sequestration of recirculating gamma delta T cells in TNF-alpha-stimulated lymph nodes.

A J Young1, T J Seabrook, W L Marston, L Dudler, J B Hay.   

Abstract

TNF-alpha is one of the most potent immunoregulatory molecules in vivo. In addition to important regulatory effects, it is also a potent inducer of extravascular lymphocyte infiltration. To examine the dynamic changes that are induced in local lymphocyte migration through regional lymph nodes following TNF-alpha injection, we used a protocol of direct lymphatic cannulation to quantitatively and qualitatively examine the traffic of lymphocytes through regional lymph nodes. We observed that local TNF-alpha injection reduced the output of lymphocytes from lymph nodes up to 90% within 6-10 h following stimulation. TNF-alpha also altered the specificity of migration of lymphocyte traffic through subcutaneous lymph nodes. In addition to the decreased output, phenotypic analysis demonstrated decreases in the concentration of gamma delta T cells by up to 30% following TNF-alpha injection. Histological examination showed that the gamma delta T cells were found in close association with VCAM-1-expressing cells in TNF-stimulated lymph nodes, at least some of which appeared to be lymphatic endothelium. These data indicate that TNF-alpha is capable of altering the number and specificity of lymphocytes recirculating through stimulated lymph nodes by selectively altering the entry of lymphocytes into the efferent lymphatics of inflamed lymph nodes in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602056     DOI: 10.1002/1521-4141(200001)30:1<327::AID-IMMU327>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Lymph, lymphocytes, and lymphatics.

Authors:  B Ristevski; H Becker; M Cybulsky; T Seabrook; S Bak; E Chan; M Johnston; J B Hay
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.

Authors:  Liguo Niu; Simona Strahotin; Becker Hewes; Benyue Zhang; Yuanyuan Zhang; David Archer; Trent Spencer; Dirck Dillehay; Byoung Kwon; Lieping Chen; Anthony T Vella; Robert S Mittler
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  A novel mechanism of immune regulation: interferon-gamma regulates retention of CD4 T cells during delayed type hypersensitivity.

Authors:  Tim J Seabrook; Paul J Borron; Lisbeth Dudler; John B Hay; Alan J Young
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

4.  Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection.

Authors:  Kevin B Walsh; David Marsolais; Megan J Welch; Hugh Rosen; Michael B A Oldstone
Journal:  Virology       Date:  2009-12-03       Impact factor: 3.616

Review 5.  New roles for mast cells in modulating allergic reactions and immunity against pathogens.

Authors:  Alison M Hofmann; Soman N Abraham
Journal:  Curr Opin Immunol       Date:  2009-10-12       Impact factor: 7.486

6.  Rotavirus infection causes mesenteric lymph node hypertrophy independently of type I interferon or TNF-α in mice.

Authors:  Joy Nakawesi; Getachew Muleta Konjit; Dragos-Christian Dasoveanu; Bengt Johansson-Lindbom; Katharina Lahl
Journal:  Eur J Immunol       Date:  2021-01-22       Impact factor: 5.532

7.  An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.

Authors:  Louise A Johnson; Steven Clasper; Andrew P Holt; Patricia F Lalor; Dilair Baban; David G Jackson
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

8.  Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress.

Authors:  O Schulz; M Ugur; M Friedrichsen; K Radulovic; J-H Niess; S Jalkanen; A Krueger; O Pabst
Journal:  Mucosal Immunol       Date:  2013-12-18       Impact factor: 7.313

9.  Cognate antigen stimulation generates potent CD8(+) inflammatory effector T cells.

Authors:  Hsueh-Cheng Sung; Sara Lemos; Patricia Ribeiro-Santos; Kateryna Kozyrytska; Florence Vasseur; Agnès Legrand; Alain Charbit; Benedita Rocha; César Evaristo
Journal:  Front Immunol       Date:  2013-12-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.